Let-7a microRNA levels in KRAS-mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR

被引：0
|
作者：
Canestrari, E.
Ruzzo, A.
Vincenzi, B.
Galluccio, N.
Perrone, G.
Andreoni, F.
Lorenzini, P.
Rulli, E.
d'Emidio, S.
Catalano, V.
Loupakis, F.
Bisonni, R.
Floriani, I.
De Nictolis, M.
Santini, D.
Salvatore, L.
Tonini, G.
Falcone, A.
Magnani, M.
Graziano, F.
机构：
[1] Univ Urbino, Sect Biochem & Mol Biol, Dept Biomol Sci, I-61029 Urbino, Italy
[2] Univ Campus Biomed, Rome, Italy
[3] Univ Campus Biomed, Dept Anat Pathol, Rome, Italy
[4] Azienda Osped Osped San Salvatore, Inst Histopathol, Pesao, Italy
[5] Mario Negri Inst Pharmacol Res, Milan, Italy
[6] Azienda Osped Osped San Salvatore, Dept Oncohematol, Div Med Oncol, Pesaro, Italy
[7] Azienda Osped Univ Pisana, Ist Toscano Tumori, UO Oncol Med 2, Pisa, Italy
[8] Osped Murri, Fermo, Italy
[9] Ist Ric Farmacol, Lab Clin Trials, Dept Oncol, Milan, Italy
[10] Univ Campus Biomed Roma, Dipartimento Med Oncol, Rome, Italy
[11] Univ Pisa, Div Med Oncol 2, Azienda Osped Univ Pisana, Ist Toscano Tumori, Pisa, Italy
[12] Univ Urbino, Dept Biomol Sci, Sect Biochem & Mol Biol, I-61029 Urbino, Italy
[13] Azienda Osped, Div Med Oncol, Dept Oncohematol, Pesaro, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.3635
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3635
引用
收藏
页数：1
相关论文
共 26 条
  • [1] High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
    Ruzzo, Annamaria
    Graziano, Francesco
    Vincenzi, Bruno
    Canestrari, Emanuele
    Perrone, Giuseppe
    Galluccio, Nadia
    Catalano, Vincenzo
    Loupakis, Fotios
    Rabitti, Carla
    Santini, Daniele
    Tonini, Giuseppe
    Fiorentini, Giammaria
    Rossi, David
    Falcone, Alfredo
    Magnani, Mauro
    ONCOLOGIST, 2012, 17 (06): : 823 - 829
  • [2] Clinical Relevance of KRAS-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy
    Laurent-Puig, Pierre
    Pekin, Deniz
    Normand, Corinne
    Kotsopoulos, Steve K.
    Nizard, Philippe
    Perez-Toralla, Karla
    Rowell, Rachel
    Olson, Jeff
    Srinivasan, Preethi
    Le Corre, Delphine
    Hor, Thevy
    El Harrak, Zakaria
    Li, Xinyu
    Link, Darren R.
    Bouche, Olivier
    Emile, Jean-Francois
    Landi, Bruno
    Boige, Valerie
    Hutchison, J. Brian
    Taly, Valerie
    CLINICAL CANCER RESEARCH, 2015, 21 (05) : 1087 - 1097
  • [3] MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF
    Mosakhani, Neda
    Lahti, Leo
    Borze, Ioana
    Karjalainen-Lindsberg, Marja-Liisa
    Sundstrom, Jari
    Ristamaki, Raija
    Osterlund, Pia
    Knuutila, Sakari
    Sarhadi, Virinder Kaur
    CANCER GENETICS, 2012, 205 (11) : 545 - 551
  • [4] Overall survival of patients with metastatic KRAS wild type colorectal cancer patients treated with anti-EGFR third line monotherapy
    Debska-Szmich, Sylwia
    Krakowska, Magdalena
    Staniecka, Katarzyna
    Krzeptowska, Paulina
    Debski, Jakub
    Dzierzak, Maria
    Wasik, Magdalena
    Gadzinowska, Joanna
    Habib-Lisik, Maja
    ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (06): : 402 - 405
  • [5] MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies
    Cappuzzo, Federico
    Sacconi, Andrea
    Landi, Lorenza
    Ludovini, Vienna
    Biagioni, Francesca
    D'Incecco, Armida
    Capodanno, Alessandra
    Salvini, Jessica
    Corgna, Enrichetta
    Cupini, Samanta
    Barbara, Cecilia
    Fontanini, Gabriella
    Crino, Lucio
    Blandino, Giovanni
    CLINICAL COLORECTAL CANCER, 2014, 13 (01) : 37 - U62
  • [6] Heterogeneity of acquired KRAS and EGFR mutations in colorectal cancer patients treated with anti-EGFR monoclonal antibodies.
    Morelli, M. Pia
    Overman, Michael J.
    Dasari, Arvind
    Kazmi, Syed Mohammad Ali
    Sanchez, Eduardo Vilar
    Eng, Cathy
    Kee, Bryan K.
    Deaton, Laurel
    Garrett, Chris R.
    Diehl, Frank
    Angenendt, Philipp
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Skin Toxicity as a Predictor of Survival in Metastatic Colorectal Cancer Patients Treated with Anti-EGFR: Fact or Fallacy?
    Chiang, Ting-Yu
    Hsu, Hung-Chih
    Chern, Yih-Jong
    Liao, Chun-Kai
    Hsu, Yu-Jen
    Tsai, Wen-Sy
    Hsieh, Pao-Shiu
    Lin, Yu-Fen
    Lee, Hsiu-Lan
    You, Jeng-Fu
    CANCERS, 2023, 15 (06)
  • [8] MicroRNA-31 May Predict Response in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR Therapy
    Mitsuhashi, Kei
    Nosho, Katsuhiko
    Igarashi, Hisayoshi
    Ito, Miki
    Naito, Takafumi
    Sukawa, Yasutaka
    Okuda, Hiroyuki
    Yoshii, Shinji
    Kusumi, Takaya
    Hosokawa, Masao
    Yamamoto, Eiichiro
    Suzuki, Hiromu
    Yamamoto, Hiroyuki
    Imai, Kohzoh
    Shinomura, Yasuhisa
    GASTROENTEROLOGY, 2014, 146 (05) : S329 - S330
  • [9] Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan
    F Graziano
    E Canestrari
    F Loupakis
    A Ruzzo
    N Galluccio
    D Santini
    M Rocchi
    B Vincenzi
    L Salvatore
    C Cremolini
    C Spoto
    V Catalano
    S D'Emidio
    P Giordani
    G Tonini
    A Falcone
    M Magnani
    The Pharmacogenomics Journal, 2010, 10 : 458 - 464
  • [10] Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan
    Graziano, F.
    Canestrari, E.
    Loupakis, F.
    Ruzzo, A.
    Galluccio, N.
    Santini, D.
    Rocchi, M.
    Vincenzi, B.
    Salvatore, L.
    Cremolini, C.
    Spoto, C.
    Catalano, V.
    D'Emidio, S.
    Giordani, P.
    Tonini, G.
    Falcone, A.
    Magnani, M.
    PHARMACOGENOMICS JOURNAL, 2010, 10 (05): : 458 - 464
123